AUTL vs ENTX: stock comparison and AI forecast
Autolus Therapeutics Plc (AUTL) and Entera Bio Ltd. (ENTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AUTL Autolus Therapeutics Plc
- Market Cap
- $341M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
ENTX Entera Bio Ltd.
- Price
- $2.99 +118.2% · 6M
- Market Cap
- $518M
- P/E Ratio
- 9.1x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ENTX is 1.5 times larger than AUTL by market capitalization ($518M against $341M).
- AUTL carries 2.37 times debt per unit of equity, against 1.68 times for ENTX.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AUTL | ENTX |
|---|---|---|
| Market Cap | $341M | $518M |
| P/E Ratio | – | 9.06x |
| P/B Ratio | 3.06x | 71.25x |
| EPS | $-1.05 | $0.33 |
| Book Value/Share | $0.42 | $0.04 |
| Revenue/Share | $0.38 | $0.00 |
| FCF/Share | $-0.87 | $-0.06 |
Profitability & Margins
| Metric | AUTL | ENTX |
|---|---|---|
| ROIC | – | -82.9% |
| Gross Margin | 1.1% | – |
| Tax Rate | -0.2% | – |
Financial Health
| Metric | AUTL | ENTX |
|---|---|---|
| Current Ratio | 4.89x | 8.98x |
| Quick Ratio | 4.40x | – |
| D/E Ratio | 2.37x | 1.68x |
| Financial Leverage | – | 2.68x |
| Interest Coverage | 16.4x | – |
| Working Capital | $267M | $17M |
Cash Flow
| Metric | AUTL | ENTX |
|---|---|---|
| Operating Cash Flow | -$226M | -$11M |
| Free Cash Flow | -$233M | -$11M |
| Capital Spending | -$7M | -$70K |
| FCF/Sales | -232.4% | – |
| CapEx/Sales | 7.1% | – |
Operational Efficiency
| Metric | AUTL | ENTX |
|---|---|---|
| Asset Turnover | – | 0.00x |
| Receivables Turnover | 2.3x | – |
| Inventory Turnover | 3.0x | – |
| Fixed Assets Turnover | 1.6x | 0.0x |
| Days Sales Outstanding | 162 days | – |
| Days Inventory | 123 days | – |
| Payables Period | 5 days | – |
| Cash Conversion Cycle | 280 days | – |
Income Statement
| Metric | AUTL | ENTX |
|---|---|---|
| Total Revenue | $100M | $0.00M |
| Operating Income | -$247M | -$14M |
| R&D Expense | $113M | $9M |
| SG&A Expense | $153M | $550K |
| Cost of Goods Sold | $99M | $0.00M |
Dividend & Shareholder Information
| Metric | AUTL | ENTX |
|---|---|---|
| Shares Outstanding | 266M | 173M |
| EPS Growth | – | 32.0% |
AUTL vs ENTX: stock comparison and AI forecast
Which is bigger, AUTL or ENTX?
ENTX is 1.5 times larger than AUTL by market capitalization ($518M against $341M).
Which one does Intratio's AI model rank higher, AUTL or ENTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.